Objective To investigate the relationship between serum levels of tumor necrosis factor-related protein 5(CTRP5),fibronectin-3(Ficolin-3),and CXC chemokine ligand 12(CXCL12)and microvascular lesions in patients with type 2 diabetes mellitus(T2DM).Methods A total of 75 patients with T2DM microangiopathy admitted to the Seventh People's Hos-pital of Zhengzhou from January 2023 to June 2024 were selected as the observation group.At the same time,150 T2DM pa-tients without microangiopathy were included as the control group according to the principle of 1∶2 matching of age,gender and body mass index(BMI).The general information,blood glucose indicators,Homa-insulin resistance(HOMA-IR),and serum CTRP5,Ficolin-3,and CXCL12 levels of the two groups were statistically analyzed by hospital medical staff.The Logistic re-gression equation was used to analyze the influencing factors of the onset of microvascular lesions in T2DM.The relationship be-tween the levels of serum CTRP5,Ficolin-3,and CXCL12 and microvascular lesions in T2DM was analyzed using smooth curve fitting method.The receiver operating characteristic(ROC)curve and area under the curve(AUC)were used to analyze the pre-dictive value of serum CTRP5,Ficolin-3,and CXCL12 for T2DM microvascular lesions.Results There were no significant differences in gender,age,BMI,duration of T2DM,abdominal circumference,DBP,SBP,TC,HDL-C,TG,LDL-C,smoking his-tory and drinking history between the two groups(all P＞0.05).FPG,2hPG,HbA1c and HOMA-IR in the observation group were significantly higher than in the control group(all P＜0.05).The serum levels of CTRP5,Ficolin-3 and CXCL12 in the ob-servation group were significantly higher than in the control group(all P＜0.05).Logistic regression analysis showed that FPG,2hPG,HbA1c,HOMA-IR,CTRP5,Ficolin-3 and CXCL12 were the influencing factors of T2DM microangiopathy(all P＜0.05).After adjusting for FPG,2hPG,HbA1c,HOMA-IR and other confounding factors,the relationship between serum Fico-lin-3,CTRP5,CXCL12 and T2DM microangiopathy was analyzed by curve fitting,the results showed that serum Ficolin-3,CTRP5,CXCL12 were linearly positively correlated with T2DM microangiopathy,with the increase of their levels,the risk of T2DM microangiopathy increased.The ROC curve showed that the AUC of serum Ficolin-3,CTRP5 and CXCL12 levels in pre-dicting T2DM microvascular lesions was 0.756,0.761 and 0.791,respectively.The AUC of combined prediction was 0.931,and the sensitivity and specificity were 90.67％and 80.00％,respectively.Delong test showed that the AUC of combined prediction was significantly greater than that of single prediction(Z=32.123,P＜0.01).Conclusion The changes in serum levels of CTRP5,Ficolin-3,and CXCL12 are closely related to microvascular lesions in patients with T2DM,providing a reference for ear-ly clinical prediction and evaluation of microvascular lesions in patients with T2DM,as well as for the development of corre-sponding intervention strategies.

Objective To investigate the relationship between serum levels of tumor necrosis factor-related protein 5(CTRP5),fibronectin-3(Ficolin-3),and CXC chemokine ligand 12(CXCL12)and microvascular lesions in patients with type 2 diabetes mellitus(T2DM).Methods A total of 75 patients with T2DM microangiopathy admitted to the Seventh People's Hos-pital of Zhengzhou from January 2023 to June 2024 were selected as the observation group.At the same time,150 T2DM pa-tients without microangiopathy were included as the control group according to the principle of 1∶2 matching of age,gender and body mass index(BMI).The general information,blood glucose indicators,Homa-insulin resistance(HOMA-IR),and serum CTRP5,Ficolin-3,and CXCL12 levels of the two groups were statistically analyzed by hospital medical staff.The Logistic re-gression equation was used to analyze the influencing factors of the onset of microvascular lesions in T2DM.The relationship be-tween the levels of serum CTRP5,Ficolin-3,and CXCL12 and microvascular lesions in T2DM was analyzed using smooth curve fitting method.The receiver operating characteristic(ROC)curve and area under the curve(AUC)were used to analyze the pre-dictive value of serum CTRP5,Ficolin-3,and CXCL12 for T2DM microvascular lesions.Results There were no significant differences in gender,age,BMI,duration of T2DM,abdominal circumference,DBP,SBP,TC,HDL-C,TG,LDL-C,smoking his-tory and drinking history between the two groups(all P＞0.05).FPG,2hPG,HbA1c and HOMA-IR in the observation group were significantly higher than in the control group(all P＜0.05).The serum levels of CTRP5,Ficolin-3 and CXCL12 in the ob-servation group were significantly higher than in the control group(all P＜0.05).Logistic regression analysis showed that FPG,2hPG,HbA1c,HOMA-IR,CTRP5,Ficolin-3 and CXCL12 were the influencing factors of T2DM microangiopathy(all P＜0.05).After adjusting for FPG,2hPG,HbA1c,HOMA-IR and other confounding factors,the relationship between serum Fico-lin-3,CTRP5,CXCL12 and T2DM microangiopathy was analyzed by curve fitting,the results showed that serum Ficolin-3,CTRP5,CXCL12 were linearly positively correlated with T2DM microangiopathy,with the increase of their levels,the risk of T2DM microangiopathy increased.The ROC curve showed that the AUC of serum Ficolin-3,CTRP5 and CXCL12 levels in pre-dicting T2DM microvascular lesions was 0.756,0.761 and 0.791,respectively.The AUC of combined prediction was 0.931,and the sensitivity and specificity were 90.67％and 80.00％,respectively.Delong test showed that the AUC of combined prediction was significantly greater than that of single prediction(Z=32.123,P＜0.01).Conclusion The changes in serum levels of CTRP5,Ficolin-3,and CXCL12 are closely related to microvascular lesions in patients with T2DM,providing a reference for ear-ly clinical prediction and evaluation of microvascular lesions in patients with T2DM,as well as for the development of corre-sponding intervention strategies.

OBJECTIVE:To evaluate the research and application situation of Sunshine Medicine Electronic Monitoring Data Analysis System. METHODS:The Sunshine Medicine Electronic Monitoring data Analysis System based on business intelligence technology was introduced in respects of design process,development,implementation and application example. RESULTS:The whole architecture of the system mainly includes hospital business platform,data integration platform,information processing plat-form and application service platform;the functions of the system include medicine homepage show,single species analysis,antimi-crobial agent analysis,national essential medicine analysis,injection analysis and sunshine medicine analysis. It can monitor the drug utilization in multi-angle and multi-level manners by building data center and creating multidimensional models. Besides,the sys-tem could solve thedrugs unified coding and information controlproblems,data collection and information integrationprob-lems in different hospital,andthe efficient calculation and analysis of a large number of drug use data. It can realize drug analy-sis and monitoring in the hospital,analysis and online monitoring of drugs prescribed by the doctor,finding,warning and evaluat-ing abnormal phenomenon of drug use in the medical institutions,so that it is better for the supervisors to monitor the usage of drugs. CONCLUSIONS:The system with easy operation,flexible monitoring,rich chart shows,comprehensive monitor index has a positive effect on rational medication level.